Scout | DOD Amyotrophic Lateral Sclerosis, Therapeutic Development Award

This opportunity is no longer accepting applications.

grant

DOD Amyotrophic Lateral Sclerosis, Therapeutic Development Award

The FY25 Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Development Award supports research advancing from preclinical validation to FDA IND-enabling studies for ALS therapies. Proposals should be empirical, product-driven, and involve collaborators with significant ALS expertise. Applicants must begin with lead compounds and proof-of-concept efficacy data from preclinical …

Source

Agency: Dept. of the Army -- USAMRAA

Award

Total Funding: $10.5M

Dates

Solicitation Posted: April 18, 2025

Application Response Due: August 27, 2025

Solicitation Closed: September 26, 2025

Eligibility

Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Keywords

1. Amyotrophic Lateral Sclerosis (ALS) 2. Therapeutic Development 3. Preclinical Validation 4. Investigational New Drug (IND) 5. Biomarker Development 6. Drug Efficacy 7. ALS Model Systems 8. Pharmacodynamic Biomarkers 9. FDA Studies 10. Collaborative Research

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers